Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first … -
JC Schymick, SW Scholz, HC Fung, A Britton, S … - Lancet Neurology, 2007 - Elsevier
... sclerosis The Lancet Neurology, Volume 6, Issue 4, April 2007, Pages 291 ... normal controls:
first stage analysis and public release of data, Lancet Neurol 5 ...
Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis -
M Pai, D Menzies - Clin Infect Dis, 2007 - UChicago Press
... 1058-4838/2007/4401-0013$15.00. DOI: 10.1086/509927. EDITORIAL COMMENTARY. ... Lancet
2006; 367:1328?34 ... potential uses of a novel gamma interferon release assay for ...
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in … -
A Hjalmarson, S Goldstein, B Fagerberg, H Wedel, F … - JAMA, 2000 - Am Med Assoc
... JAMA-EXPRESS Effects of Controlled-Release Metoprolol on Total Mortality,
Hospitalizations, and Well-being in Patients With Heart Failure ...
A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive … -
… , A Khoury, A Lorber, B Goldman, D Lancet, M Eldar - The American Journal of Human Genetics, 2001 - Elsevier
... Avraham Lorber 4 , Boleslaw Goldman 1 , Doron Lancet 3 and ... Available online 2 November
2007. ... a cardiac sarcoplasmic reticulum (SR) Ca 2+ -release channel, were ...
Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in … -
K Beardshall, S Moss, J Gill, S Levi, P Ghosh, RJ … - British Medical Journal, 1992 - gut.bmj.com
... 2007 gut.bmj.com Downloaded from Page 2. Gut, 1992,33,601-603 Suppression
ofHelicobacterpylori reduces gastrin releasing peptide stimulated gastrin release ...
Lancet device -
US Patent 4,817,603, 1989 - freepatentsonline.com
... 2 with the lancet needle released from the retracted position ... the assembly, firing
and disassembly of the lancet device ... Copyright 2004-2007 FreePatentsOnline.com ...
ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association … -
MA van Es, PW Van Vught, HM Blauw, L Franke, CG … - Lancet Neurology, 2007 - Elsevier
... The Lancet Neurology, Volume 6, Issue 10, October 2007, Pages 841 ... stimulation of
glutamate receptors, inositol 1,4,5-trisphosphate is released and then ...
Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment … -
SA Riley, V Mani, MJ Goodman, ME Herd, S Dutt, LA … - British Medical Journal, 1988 - gut.bmj.com
... 670 on 17 September 2007 gut.bmj.com Downloaded from Page 4. Comparison of delayed
release 5 aminosalicylic acidand sulphasalazine in ulcerative colitis relapse ...
Slow release carbohydrate and the treatment of diabetes -
DJA Jenkins, TMS Wolever - Proceedings of the Nutrition Society, 2007 - Cambridge Univ Press
... 4). The wholemeal bread released its carbohydrate products most rapidly and the ... again
demonstrated the importance of the rate of release in determining the ...
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy -
MJ Brodie, E Perucca, P Ryvlin, E Ben-Menachem, HJ … - Neurology, 2007 - AAN Enterprises
... NEUROLOGY 2007;68:402-408 ? 2007 American Academy of Neurology ... 6 In this regard,
a controlled-release formulation of CBZ was used ... Lancet Neurol 2004;729?735. ...
Source: Google Scholar |